Oric Pharmaceuticals Inc — Quarterly Dividends (NASDAQ:ORIC) | MetaTrader

Open full chart

Nouvelles

H.C. Wainwright relève l’objectif de cours d’ORIC Pharmaceuticals

H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress

Oppenheimer réitère sa recommandation Surperformance sur ORIC, objectif 15$

Oppenheimer reiterates Outperform on ORIC stock, $15 target

Oric Pharmaceuticals dépose un nouveau prospectus d’offre au marché de 200 millions de dollars

Oric Pharmaceuticals files new $200 million at-the-market offering prospectus

Le directeur d’Oric Pharmaceuticals, Heyman, vend des actions pour 80.430€

Oric Pharmaceuticals director Heyman sells shares worth $80,430

ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)

Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80

H.C. Wainwright maintient sa recommandation d’achat sur l’action ORIC Pharmaceuticals

H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock